119-HR1244
Reducing Drug Prices for Seniors Act
Last action was on 2-12-2025
SenateCurrent status is Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View Official Bill Information at congress.govNo users have voted for/against support on this bill yet. Be the first!
119th CONGRESS
1st Session
H. R. 1244
1. Short title2. Requiring that coinsurance for drugs under Medicare part D be based on the drug's actual acquisition cost and not the drug's wholesale acquisition cost1. Short title
This Act may be cited as the "Reducing Drug Prices for Seniors Act".
2. Requiring that coinsurance for drugs under Medicare part D be based on the drug's actual acquisition cost and not the drug's wholesale acquisition cost
Section 1860D–2 of the Social Security Act (42 U.S.C. 1395w–102) is amended—
(1) Requirement that coinsurance for covered part D drugs be based on the actual acquisition cost of the drug - in subsection (b)—
(A) - in paragraph (2)(A), in the matter preceding clause (i), by striking "and (9)" and inserting ", (9), and (10)"; and
(B) Requirement that coinsurance for covered part D drugs be based on the actual acquisition cost of the drug - by adding at the end the following new paragraph:
(10) Requirement that coinsurance for covered part D drugs be based on the actual acquisition cost of the drug -
(A) In general - For plan years beginning on or after January 1, 2026, for costs above the annual deductible specified in paragraph (1) and below the annual out-of-pocket threshold specified in paragraph (4), any coinsurance amount for a covered part D drug (insofar as such covered part D drug is included on the formulary and subject to coinsurance rather than a copayment) shall be calculated based on the actual acquisition cost (and not the wholesale acquisition cost) of such covered part D drug if such actual acquisition cost is lower than the wholesale acquisition cost of such covered part D drug. The preceding sentence shall not apply to a covered part D drug described in paragraph (8) or (9).
(B) Actual acquisition cost defined - In this paragraph, the term "actual acquisition cost" means, with respect to a covered part D drug, the negotiated price of the covered part D drug under the prescription drug plan or MA–PD plan, net of any manufacturer-provided price concessions (as defined under section 423.100 of title 42, Code of Federal Regulations (or any successor regulation)), as reported for such drug in the Detailed DIR Report (or any successor report) submitted by the sponsor or organization offering the plan for the previous plan year.
(2) Requirement that coinsurance for covered part D drugs be based on the net price of the drug - in subsection (c), by adding at the end the following new paragraph:
(7) Requirement that coinsurance for covered part D drugs be based on the net price of the drug - The coverage is provided in accordance with subsection (b)(10).